The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mammals, Lsm1 dysregulation is linked to tumorigenesis and immune programs [29–31].”
From The Lsm1–7 complex couples 3′-end protection to histone H4 acetylation to maintain mRNA homeostasis in Fusarium graminearum (2026) · cites this paper as [30]
In the citing paper
“Our data are also consistent with mammalian studies showing that Lsm1 promotes metabolic reprogramming by stabilizing glycolytic transcripts [30, 31].”
From The Lsm1–7 complex couples 3′-end protection to histone H4 acetylation to maintain mRNA homeostasis in Fusarium graminearum (2026) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Research works printed but not linked: 57
- Li, 2019, The molecular mechanism of epithelial-mesenchymal transition for breast carcinogenesis, Biomolecules, 9, 10.3390/biom9090476 · DOI
- Chu, 2022, Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer, Aging (Albany NY), 14, 2252, 10.18632/aging.203933 · DOI
- Lin, 2023, Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer, J. Transl. Med, 21, 10.1186/s12967-023-04035-4 · DOI
- Tarchi, 2023, Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis, J. Transl. Med, 21, 10.1186/s12967-023-04457-0 · DOI
- Li, 2021, PD‑L1/PD‑1 blockade in breast cancer: the immunotherapy era, Oncol. Rep., 45, 5, 10.3892/or.2020.7831 · DOI
- Wilusz, 2013, Lsm proteins and Hfq: Life at the 3' end, RNA Biol., 10, 592, 10.4161/rna.23695 · DOI
- Montemayor, 2020, Molecular basis for the distinct cellular functions of the Lsm1-7 and Lsm2-8 complexes, RNA, 26, 1400, 10.1261/rna.075879.120 · DOI · Paper page
- Little, 2016, The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells, Oncogenesis, 5, 10.1038/oncsis.2015.45 · DOI · Paper page
- Bouveret, 2000, A Sm-like protein complex that participates in mRNA degradation, EMBO J., 19, 1661, 10.1093/emboj/19.7.1661 · DOI · Paper page
- Sheth, 2003, Decapping and decay of messenger RNA occur in cytoplasmic processing bodies, Science, 300, 805, 10.1126/science.1082320 · DOI · Paper page
- Streicher, 2007, Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon, Oncogene, 26, 2104, 10.1038/sj.onc.1210002 · DOI
- Noblejas-Lopez, 2021, Genomic mapping of splicing-related genes identify amplifications in LSM1, CLNS1A, and ILF2 in luminal breast cancer, Cancers, 13, 10.3390/cancers13164118 · DOI
- Ta, 2021, Potential therapeutic and prognostic values of LSM family genes in breast cancer, Cancers, 13, 10.3390/cancers13194902 · DOI
- Tzeng, 2022, Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer, J. Cell Mol. Med, 26, 4007, 10.1111/jcmm.17436 · DOI
- Watson, 2008, CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes, Am. J. Respir. Cell Mol. Biol., 38, 671, 10.1165/rcmb.2007-0205OC · DOI
- Peng, 2023, Interactions between MFAP5 + fibroblasts and tumor-infiltrating myeloid cells shape the malignant microenvironment of colorectal cancer, J. Transl. Med, 21, 10.1186/s12967-023-04281-6 · DOI
- Peng, 2022, Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer, J. Transl. Med, 20, 10.1186/s12967-022-03510-8 · DOI · Paper page
- Wang, 2022, Metabolism and polarization regulation of macrophages in the tumor microenvironment, Cancer Lett., 543, 10.1016/j.canlet.2022.215766 · DOI
- de Goede, 2020, Metabolic cancer-macrophage crosstalk in the tumor microenvironment, Biol. (Basel), 9
- Sciacovelli, 2016, Oncometabolites: unconventional triggers of oncogenic signalling cascades, Free Radic. Biol. Med, 100, 175, 10.1016/j.freeradbiomed.2016.04.025 · DOI · Paper page
- Martinez, 2008, Macrophage activation and polarization, Front Biosci., 13, 453, 10.2741/2692 · DOI · Paper page
- Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu Rev. Immunol., 27, 451, 10.1146/annurev.immunol.021908.132532 · DOI · Paper page
- Li, 2023, Metabolism, metabolites, and macrophages in cancer, J. Hematol. Oncol., 16, 10.1186/s13045-023-01478-6 · DOI · Paper page
- Bernard-Pierrot, 2008, Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer, Cancer Res, 68, 7165, 10.1158/0008-5472.CAN-08-1360 · DOI
- Yang, 2010, Transforming properties of 8p11-12 amplified genes in human breast cancer, Cancer Res, 70, 8487, 10.1158/0008-5472.CAN-10-1013 · DOI
- Li, 2021, Acetyl coenzyme a synthase 2 Acts as a prognostic biomarker associated with immune infiltration in cervical squamous cell carcinoma, Cancers, 13, 10.3390/cancers13133125 · DOI
- Bartha, 2021, TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues, Int J. Mol. Sci., 22, 10.3390/ijms22052622 · DOI · Paper page
- Chandrashekar, 2017, UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 · DOI · Paper page
- Li, 2021, Identification of novel biomarkers and candidate drug in ovarian cancer, J. Pers. Med, 11, 10.3390/jpm11040316 · DOI
- Chu, 2021, Multi-omics reveals the immunological role and prognostic potential of mitochondrial ubiquitin ligase MARCH5 in human breast cancer, Biomedicines, 9, 10.3390/biomedicines9101329 · DOI
- Gyorffy, 2021, Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer, Comput. Struct. Biotechnol. J., 19, 4101, 10.1016/j.csbj.2021.07.014 · DOI · Paper page
- Liao, 2022, Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer, Pathol. Res Pr., 240
- Li, 2022, Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma, Int Immunopharmacol., 112, 10.1016/j.intimp.2022.109273 · DOI
- Li, 2021, Dehydroepiandrosterone shifts energy metabolism to increase mitochondrial biogenesis in female fertility with advancing age, Nutrients, 13, 10.3390/nu13072449 · DOI
- Li, 2015, Synergistic protection of N-acetylcysteine and ascorbic acid 2-phosphate on human mesenchymal stem cells against mitoptosis, necroptosis and apoptosis, Sci. Rep., 5
- Liao, 2017, Development of a postcolumn infused-internal standard liquid chromatography mass spectrometry method for quantitative metabolomics studies, J. Proteome Res, 16, 1097, 10.1021/acs.jproteome.6b01011 · DOI
- Tsai, 2022, Expression status and prognostic significance of mitochondrial dynamics OPA3 in human ovarian cancer, Aging (Albany NY), 14, 3874, 10.18632/aging.204050 · DOI
- Galluzzi, 2018, Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018, Cell Death Differ., 25, 486, 10.1038/s41418-017-0012-4 · DOI · Paper page
- Chiu, 2021, Molecular machinery and pathophysiology of mitochondrial dynamics, Front Cell Dev. Biol., 9, 10.3389/fcell.2021.743892 · DOI
- Gomes, 2011, During autophagy mitochondria elongate, are spared from degradation and sustain cell viability, Nat. Cell Biol., 13, 589, 10.1038/ncb2220 · DOI · Paper page
- Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394
- Wang, 2020, The metabolic mechanisms of breast cancer metastasis, Front Oncol., 10
- Schwartzenberg-Bar-Yoseph, 2004, The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression, Cancer Res, 64, 2627, 10.1158/0008-5472.CAN-03-0846 · DOI · Paper page
- Jiang, 2011, p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase, Nat. Cell Biol., 13, 310, 10.1038/ncb2172 · DOI · Paper page
- Fruman, 2014, PI3K and cancer: lessons, challenges and opportunities, Nat. Rev. Drug Discov., 13, 140, 10.1038/nrd4204 · DOI · Paper page
- Araki, 2018, Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer, Breast Cancer, 25, 392, 10.1007/s12282-017-0812-x · DOI · Paper page
- McCarthy, 2020, Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer, BMC Cancer, 20, 10.1186/s12885-020-06810-8 · DOI
- Ning, 2023, NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway, J. Transl. Med, 21
- Pavlova, 2016, The emerging hallmarks of cancer metabolism, Cell Metab., 23, 27, 10.1016/j.cmet.2015.12.006 · DOI · Paper page
- Chen, 2021, Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma, Transl. Cancer Res, 10, 1744, 10.21037/tcr-20-3056 · DOI
- Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI · Paper page
- Qiu, 2018, Tumor-associated macrophages in breast cancer: Innocent bystander or important player?, Cancer Treat. Rev., 70, 178, 10.1016/j.ctrv.2018.08.010 · DOI · Paper page
- Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J. Cancer, 117, 701, 10.1002/ijc.21422 · DOI · Paper page
- Casazza, 2013, Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity, Cancer Cell, 24, 695, 10.1016/j.ccr.2013.11.007 · DOI · Paper page
- Henze, 2016, The impact of hypoxia on tumor-associated macrophages, J. Clin. Invest, 126, 3672, 10.1172/JCI84427 · DOI · Paper page
- Colegio, 2014, Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, 513, 559, 10.1038/nature13490 · DOI · Paper page
- Cai, 2023, Correlation between LSM1 expression and clinical outcomes in glioblastoma and functional mechanisms, Int J. Genom., 2023
Cited by
Ren, Y., Yan, J., Han, X., Xu, C., Guo, M., Wang, X., Liu, C., Logrieco, A. F., Jin, Y., Ma, Z., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag169 · Cited by 1
Metadata
- Authors
- Tzeng, Y.-D. T., Hsiao, J.-H., Chu, P.-Y., Tseng, L.-M., Hou, M.-F., Tsang, Y.-L., Shao, A.-N., Sheu, J. J.-C., & Li, C.-J.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 198
- Pages
- 107008
- ISSN
- 1043-6618
- Cited by
- 17
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Funders
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan (111-2314-B-075B-004-MY3, 111-2314-B-075B-017, NSTC 112-2314-B-075B-008)
- Yen Tjing Ling Medical Foundation
- Kaohsiung Veterans General Hospital
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration. https://app.cochat.ai/papers/10.1016/j.phrs.2023.107008
- The paper
- Tzeng, Y.-D. T., Hsiao, J.-H., Chu, P.-Y., Tseng, L.-M., Hou, M.-F., Tsang, Y.-L., Shao, A.-N., Sheu, J. J.-C., & Li, C.-J. (2023). The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.107008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.